4 Followers on Owler

Noxopharm

is an Australia-based biotechnology company that researches and develops oncotoxic and immuno-oncology molecule drugs to treat cancer and inflammatory diseases... Read more
OverviewCompetitorsFundingNews & Insights

Noxopharm

is an Australia-based biotechnology company that researches and develops oncotoxic and immuno-oncology molecule drugs to treat cancer and inflammatory diseases... Read more
Noxopharm Managing Director & CEO: Gisela Mautner

Managing Director & CEO

Gisela Mautner

CEO Approval Rating

82/100

2015

PublicAustralian Securities ExchangeNOX

Pharmaceuticals & Biotechnology
Biotechnology
28362834 NAICS listing

Annual Revenue
$3.8M
Employees
5
Funding
$20.1M

News

Funding
Sep 06, 2024
Proactive Investors
Noxopharm received $1.9M in Debt Funding

Noxopharm Competitors

1Pharmaxis
2aucentra
3cantheradiscovery
4Genkyotex
5Noxxon Pharma
6Antabio
7Medigene
8Immatics
9Tizona
10Innate Pharma
Unlock 12 + competitors

Trending Companies